HCA Healthcare, Inc. (NYSE:HCA – Get Free Report) major shareholder Of America Corp /De/ Bank sold 477 shares of the business’s stock in a transaction on Tuesday, January 10th. The shares were sold at an average price of $21.90, for a total transaction of $10,446.30. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Major shareholders that own 10% or more of a company’s shares are required to disclose their sales and purchases with the SEC.
HCA Healthcare Stock Performance
Shares of HCA stock opened at $342.25 on Friday. The company’s 50-day simple moving average is $324.53 and its 200-day simple moving average is $341.56. HCA Healthcare, Inc. has a one year low of $289.98 and a one year high of $417.14. The stock has a market capitalization of $84.26 billion, a price-to-earnings ratio of 15.58, a PEG ratio of 1.10 and a beta of 1.68. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.97 and a current ratio of 1.08.
HCA Healthcare (NYSE:HCA – Get Free Report) last announced its quarterly earnings data on Friday, January 24th. The company reported $6.22 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.03 by $0.19. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. During the same quarter in the previous year, the firm earned $5.90 EPS. Equities analysts anticipate that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.
HCA Healthcare Increases Dividend
Wall Street Analysts Forecast Growth
A number of equities analysts have recently commented on HCA shares. JPMorgan Chase & Co. restated a “neutral” rating and issued a $380.00 price objective on shares of HCA Healthcare in a report on Tuesday, December 17th. KeyCorp decreased their price objective on shares of HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating for the company in a research note on Tuesday, January 7th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $405.00 price target on shares of HCA Healthcare in a research report on Monday, January 27th. Royal Bank of Canada reduced their price objective on HCA Healthcare from $405.00 to $384.00 and set an “outperform” rating on the stock in a research note on Monday, January 27th. Finally, Barclays reduced their price target on HCA Healthcare from $392.00 to $366.00 and set an “overweight” rating on the stock in a research report on Monday, January 27th. One research analyst has rated the stock with a sell rating, three have given a hold rating, thirteen have given a buy rating and two have issued a strong buy rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $385.67.
Check Out Our Latest Analysis on HCA
Institutional Inflows and Outflows
Institutional investors have recently added to or reduced their stakes in the stock. Whipplewood Advisors LLC bought a new position in shares of HCA Healthcare during the fourth quarter worth about $31,000. Tidemark LLC bought a new stake in shares of HCA Healthcare during the fourth quarter valued at approximately $36,000. Legacy Investment Solutions LLC bought a new position in HCA Healthcare in the 3rd quarter worth approximately $39,000. Activest Wealth Management boosted its position in HCA Healthcare by 1,250.0% during the 4th quarter. Activest Wealth Management now owns 135 shares of the company’s stock worth $40,000 after acquiring an additional 125 shares during the period. Finally, Pinnacle Bancorp Inc. increased its holdings in shares of HCA Healthcare by 50.0% during the fourth quarter. Pinnacle Bancorp Inc. now owns 150 shares of the company’s stock valued at $45,000 after purchasing an additional 50 shares during the period. 62.73% of the stock is currently owned by institutional investors.
About HCA Healthcare
HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.
Further Reading
- Five stocks we like better than HCA Healthcare
- Stock Sentiment Analysis: How it Works
- Why Dollar Tree’s Family Dollar Sale Could Spark a Comeback
- How to Find Undervalued Stocks
- JPMorgan: The ‘NVIDIA of Banking’ Poised for More Gains?
- What Are Some of the Best Large-Cap Stocks to Buy?
- Buy the Chewy Stock Reversal? Here’s Why Now Is the Time
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.